Exaggerated urinary excretion of aquaporin-2 in the pathological state of impaired water excretion dependent upon arginine vasopressin

被引:38
作者
Saito, T [1 ]
Ishikawa, SE [1 ]
Ando, F [1 ]
Okada, N [1 ]
Nakamura, T [1 ]
Kusaka, I [1 ]
Higashiyama, M [1 ]
Nagasaka, S [1 ]
Saito, T [1 ]
机构
[1] Jichi Med Sch, Dept Med, Div Endocrinol & Metab, Minami Kawachi, Tochigi 32904, Japan
关键词
D O I
10.1210/jc.83.11.4034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study was undertaken to determine whether urinary excretion of aquaporin-2 (UAQP-2) is of value to diagnose the pathological state of water retention and hyponatremia. UAQP-2 under ad libitum water drinking was 429 fmol/mg creatinine in the patients with water retention, a value significantly greater than that of 153 fmol/mg creatinine in the normal subjects. An acute oral water load test (20 mL/kg BW) was performed in 7 normal subjects (22-25 yr old) and 10 patients with water retention and hyponatremia (55-75 yr old). The percent excretion of the water load was only 30% in the patient group compared with 70% in the control group (P < 0.01). In the control group, minimal urinary osmolality was as low as 131 mosmol/kg H2O, which was responsible for the decrease in plasma arginine vasopressin (AVP) levels after the reduction in plasma osmolality. In the patient group, minimal urinary osmolality was 320 mosmol/kg H2O, and free water clearance remained below 0.6 mL/min after the water load. This impaired water excretion was consistent with the nonsuppressible levels of plasma AVP despite hypoosmolality. The nadir of UAQP-2 was obtained at 60-90 min. The minimal UAQP-2 was reduced to 284 fmol/mg creatinine, a value significantly greater than that of 76 fmol/mg creatinine in the control group. Similar results were obtained in the 6 patients with hypopituitarism, who had impaired water excretion and marked hyponatremia. Water excretion was totally normalized after the replacement of hydrocortisone (excretion of water load, 31% us. 102%; P < 0.01). Hydrocortisone replacement also significantly reduced the minimal UAQP-5 from 225 to 49 fmol/mg creatinine after the acute oral water load, a value comparable to that in the control subjects. These results indicate that UAQP-2 is a potent marker to diagnose the pathological state of impaired water excretion and hyponatremia, dependent upon AVP, in patients with water retention and hypopituitarism.
引用
收藏
页码:4034 / 4040
页数:7
相关论文
共 40 条
[11]   IN-SITU HYBRIDIZATION ANALYSIS OF VASOPRESSIN GENE-TRANSCRIPTION IN THE PARAVENTRICULAR AND SUPRAOPTIC NUCLEI OF THE RAT - REGULATION BY STRESS AND GLUCOCORTICOIDS [J].
HERMAN, JP .
JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 363 (01) :15-27
[12]   cAMP motifs regulating transcription in the aquaporin 2 gene [J].
Hozawa, S ;
Holtzman, EJ ;
Ausiello, DA .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 270 (06) :C1695-C1702
[13]  
ISHIKAWA S, 1991, ENDOCRINOL JAPON, V38, P325
[14]   EFFECT OF ARGININE VASOPRESSIN ANTAGONIST ON RENAL WATER-EXCRETION IN GLUCOCORTICOID AND MINERALOCORTICOID DEFICIENT RATS [J].
ISHIKAWA, S ;
SCHRIER, RW .
KIDNEY INTERNATIONAL, 1982, 22 (06) :587-593
[15]   EFFECT OF VASOPRESSIN ANTAGONIST ON WATER-EXCRETION IN INFERIOR VENA-CAVA CONSTRICTION [J].
ISHIKAWA, S ;
SAITO, T ;
OKADA, K ;
TSUTSUI, K ;
KUZUYA, T .
KIDNEY INTERNATIONAL, 1986, 30 (01) :49-55
[16]   Involvement of arginine vasopressin and renal sodium handling in pathogenesis of hyponatremia in elderly patients [J].
Ishikawa, S ;
Fujita, N ;
Fujisawa, G ;
Tsuboi, Y ;
Sakuma, N ;
Okada, K ;
Saito, T .
ENDOCRINE JOURNAL, 1996, 43 (01) :101-108
[17]   CELLULAR ACTIONS OF ARGININE-VASOPRESSIN IN THE KIDNEY [J].
ISHIKAWA, SE .
ENDOCRINE JOURNAL, 1993, 40 (04) :373-386
[18]   HYPONATREMIA AND OSMOREGULATION OF THIRST AND VASOPRESSIN SECRETION IN PATIENTS WITH ADRENAL INSUFFICIENCY [J].
KAMOI, K ;
TAMURA, T ;
TANAKA, K ;
ISHIBASHI, M ;
YAMAJI, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1584-1588
[19]   URINARY-EXCRETION OF AQUAPORIN-2 IN PATIENTS WITH DIABETES-INSIPIDUS [J].
KANNO, K ;
SASAKI, S ;
HIRATA, Y ;
ISHIKAWA, S ;
FUSHIMI, K ;
NAKANISHI, S ;
BICHET, DG ;
MARUMO, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (23) :1540-1545
[20]  
Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861